2m 2m 2m 2m 2m 2m 2m
ROIVANT SCIENCES (ROIV)
NASDAQ
$36.30$0.00 (0.00%)
Price as of Aug 21, 2026 7:51 PM EDT- $25.9BMarket Cap
- 204.53%1-Year Change
- BiotechnologyIndustry
ROIVANT SCIENCES (ROIV)
$36.30$0.00 (0.00%)
ROIV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $36.30 | ||
Change | -$0.54 (-1.47%) | ||
Open | $37.03 | ||
High | $37.18 | ||
Low | $36.23 | ||
Previous Close | $36.84 | ||
Volume | 6,185,571 | ||
30-Day Average Volume | 5,496,908 | ||
1-Week Change | 0.28% | ||
1-Month Change | 3.83% | ||
1-Year Change | 204.53% | ||
3-Year Change | 231.20% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 713.5M | ||
Total Assets | $5.3B | ||
Market Cap | $25.9B | ||
Enterprise Value | $24.7B | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$189.8M | ||
Free Cash Flow | -$270.9M | ||
EBIT | -$193.8M | ||
EBITDA | -$193.2M | ||
Net Working Capital | $4.5B | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -128 | ||
Enterprise Value/Revenue | 17,097 | ||
P/B | 6 | ||
P/E | -140 | ||
PEG | 1 | ||
Price/Free Cash Flow | -96 | ||
Price/Operating Cash Flow | -96 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue